Peripheral blood DNA methylation signatures predict response to vedolizumab and ustekinumab in adult patients with Crohn’s disease: The EPIC-CD study
Authors:
Preprint
Abstract
Biological therapeutics are now widely used in Crohn’s disease (CD), with evidence of efficacy from randomized trials and real-world experience. Primary non-response is a common, poorly understood problem. We assessed blood methylation as a predictor of response to vedolizumab (VDZ, anti-a4b7 integrin) or ustekinumab (USTE, anti-IL-12/23p40). We report a two-center, prospective cohort study in which we profiled the peripheral blood DNA methylome of 184 adult male and female CD patients prior to and during treatment with VDZ or USTE in a discovery (n=126) and an external validation cohort (n=58). We defined epigenetic biomarkers that were stable over time and associated with combined clinical and endoscopic response to VDZ or USTE with an area under curve (AUC) of 0.87 and 0.89, respectively. We validated these models in an external cohort yielding an AUC of 0.75 for both VDZ and USTE. These data will now be prospectively tested in a multicenter randomized clinical trial. GraphicalKeywords
All Related Versions
- Published version: The Lancet Gastroenterology & Hepatology, 10 (9), 818.
This publication has 112 references indexed in Scilit:
- Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel DiseasesClinical Gastroenterology and Hepatology, 2019
- Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene PromotersCell, 2016
- Data Analysis2016
- How Can We Manipulate the IL-23/IL-17 Axis?Current Treatment Options in Rheumatology, 2015
- Bone Morphogenetic Protein Signaling Regulates Development and Activation of CD4+ T Cells2015
- RhoA/ROCK-dependent pathway is required for TLR2-mediated IL-23 production in human synovial macrophages: Suppression by cilostazolBiochemical Pharmacology, 2013
- Hypermethylation of EBF3 and IRX1 Genes in Synovial Fibroblasts of Patients with Rheumatoid ArthritisMolecules and Cells, 2013
- Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease SeverityClinical Gastroenterology and Hepatology, 2010
- Synergistic effect of TGF‐β superfamily members on the induction of Foxp3+ TregEuropean Journal of Immunology, 2009
- TGF-β is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23Biochemical and Biophysical Research Communications, 2009